This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Clinical Experience -
Synchronous primary carcinomas of the bladder and prostate
Sheng-Hui Lee1, Phei-Lang Chang1, 3, Shao-Ming Chen4, Guang-Huan Sun5, Chien-Lun Chen1,3, Biing-Yir Shen1, Ya-Shen Wu1, Ke-Hung Tsui1, 2, 3
1Division of Geriatric Urology, Department of Surgery, Chang Gung Memorial Hospital, Kweishan, Taoyuan 333,
Taiwan , China
2Chang Gung Institute of Technology, Chang Gung University, Kweishan, Taoyuan 333, Taiwan, China
3Chang Gung Bioinformatics Center, Kweishan, Taoyuan 333, Taiwan , China
4Department of Urology, Taipei City Hospital, Heping Branch, Taipei 100, Taiwan, China
5Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, China
Abstract
Aim: To determine the incidence of adenocarcinoma of the prostate for patients undergoing radical cystoprostatectomy
for bladder cancer in Taiwan. Methods: A total of 248 patients in Taiwan who were histologically confirmed for
transitional cell carcinoma of the bladder underwent cystoprostatectomy. Histopathologic evaluation of the prostate
specimens sectioned at 5 mm intervals was performed.
Results: Of the 248 patients, 10 (4.03%) were found to have
prostate cancer. Of the 10 cases of unsuspected prostate cancer, eight proved to be at stage T1 or T2, and two at T3
and T4, respectively. This rate of incidentally found prostate cancer amongst our bladder cancer patients appeared to
be lower than that found in bladder cancer patients in similar studies in USA.
Conclusion: Although the incidence of incidental prostate cancer in patients in Taiwan with bladder cancer is not high compared with that in Western
countries, we suggest that digital rectal examination and prostate-specific antigen (PSA) are important screening tools
for men with bladder cancer, especially for those aged 60 years and older in Taiwan.
(Asian J Androl 2006 May; 8: 357-359)
Keywords: radical cystoprostatectomy; prostate cancer; transitional cell carcinoma
Correspondence to: Dr Ke-Hung Tsui, Division of Geriatric Urology, Department of Surgery, Chang Gung Memorial Hospital, School of
Medicine, Chang Gung University, 5 Fu-Shin Street, Kweishan, Taoyuan 333, Taiwan, China.
Tel: +886-3-328-1200 ext. 2137,
Fax: +886-2-2735-8775
E-mail: khtsui@yahoo.com
Received 2005-03-17 Accepted 2005-12-23
1 Introduction
Prostate cancer is the most commonly diagnosed malignancy in men and also the leading cause of cancer-related
death in developed countries [1], but not all that common in Taiwan [2]. Prostate cancer detected in patients
undergoing cystoprostatectomy is usually an incidental finding. The prevalence of histological prostate cancer clearly
exceeds that of clinically detected prostate cancer for men in the developed world. Autopsy studies have revealed that
an incidental finding of prostate cancer in 50-year-old American men was 30%, and for 80-year-old the corresponding
figure was 70% [3]. Autopsy studies conducted in mainland China have revealed that incidental prostate cancer in
men 51-69 years was 9.3%, and that for men 70 years and older was 25% [4], both significantly lower than that for
Americans. The reasons for these rather large differences between these populations are unknown at present [6].
Cystoprostatectomy specimens obtained from patients operated on for bladder cancer provide people an
opportunity to study the relative incidental findings of prostate cancer, and several clinical studies have already reported their
data [3]. These prostate tumors are typically small, well-or moderately well-differentiated, and localized entirely
within the gland [6, 7].
Because, till now, there has been no other reports regarding incidental prostate cancer in patients in Taiwan with
bladder cancer, we conducted a retrospective analysis of a group of 248 patients in Taiwan who were treated for
bladder cancer in our hospital. Without exceptions, these bladder cancer patients had apparently clinically normal
prostate.
2 Materials and methods
From August 1993 to August 2003, 250 male patients underwent radical cystoprostatectomy for bladder transitional
cell carcinoma in our hospital. The age of the patients ranged from 33 to 82 years (mean=63 years). Preoperative
evaluations included abdominal computed tomography and bone scans.
Excluded from this study were two patients: one was previously diagnosed with prostate cancer and the other had high-grade prostate cancer with bladder invasion. A
standard cystoprostatectomy with bilateral pelvic lymphadenectomy was performed for all patients. An ileal conduit was also
performed for all cases to provide urinary diversion. The entire circumference of the resected prostate gland was inked.
Complete transverse sections of the prostate were obtained at 5mm intervals from apex to base. Tissue samples of each
cross-section were examined under microscope. If adenocarcinoma was found, then tumor grade, presence of
extracapsular disease, and evidence of seminal vesicle invasion and lymph node metastasis were recorded. The
c2-test was performed in the data analysis.
3 Results
Adenocarcinoma of the prostate was found for 10 of 248 bladder cancer patients (4.03%). Pathologic staging of
the prostate cancer revealed 8 cases of pT1-pT2N0M0, 1 of pT3N0M0 and 1 of pT4N0M0. The mean age of this
cohort of Taiwan patients presenting with both bladder cancer and prostate cancer was 71 years (range 61-81 years),
a higher figure (P=0.01) than that for those study subjects with bladder cancer only: 63 years (range 33-82 years).
The Gleason score was 2-4 in 4 cases, 5-7 in 5 cases and 8-10 in 1 case. A Gleason pattern 4 and 5 was noted
in 2 patients; all other tumor foci were graded at 3 or lower.
Table£± summarizes the results. Prostate adenocarcinoma was found in 3 of 70 patients in the age range
60-69 years (4.3%), and for those older than 70 years, it was found in 7 of 54 patients (13%). Preoperative serum
prostate-specific antigen (PSA) levels were available for 3 cases, and all were less than 4mg/mL.
4 Discussion
This study was performed to identify the clinical incidence of prostate adenocarcinoma in bladder cancer patients.
Our study found an incidence of approximately 4%. This contrasts to the reported prevalence of 27-46% for
cystoprostatectomy specimens elsewhere [6]. The present study showed a low prevalence of incidental prostate cancer
in men in Taiwan. Like the results of studies conducted in USA and Western Europe, the diagnosed cancer was primarily
localized and well differentiated [7-9]. It is well known that the incidence of prostate cancer is higher in developed
countries than that in Asian countries [5]. In our cancer cases, one adenocarcinoma showed seminal vesicle invasion and
another showed seminal vesicle and bladder invasion with a high Gleason pattern. Their serum PSA values were 1.55
ng/mL and 2.09mg/mL, respectively. The other 8 were
characterized as organ-confined. The cystoprostatectomy
procedure appeared to be an entirely adequate treatment modality for virtually all patients in our study, with only 2 of them
(0.8%) requiring further treatment for their prostate cancer. Detailed pathologic examination of the excised prostatic
tissue specimens is extremely important for the detection of small cancers. Certainly, if we examined the specimens
with transverse sectioning at 2-3mm intervals from apex to base, we might identify a greater number of tumors. In
the present study, all unsuspected prostate cancer patients proved to be older than 60 years, and within this patient
group there were 2 cases of advanced disease. The pathologic stage and grade of bladder cancer would appear to be
prognostically more important than the stage and grade of the prostate cancer. Our patients were assessed extremely
carefully preoperatively to specifically exclude concurrent prostate cancer.
We believe that digital rectal examination (DRE) and serum PSA assessment should be undertaken as part of the
routine procedure for male bladder cancer patients aged 60 years and older, although the mean age of our group of
bladder cancer patients with prostate cancer is higher than that studied in developed countries. Bladder cancer
patients presenting with an abnormal DRE, ele-vated serum PSA or a free PSA less than 15% should undergo a prostate
needle biopsy to rule out prostate cancer. If organ-confined prostate cancer is found, and if the prostate is completely
excised at cystoprostatectomy, we believe that no additional therapy would be required and that it should merely be
specified that such patients should be followed with periodic PSA. Further studies with larger sample sizes and long
follow-up periods are being carried out to establish more extensive and definitive guidelines for the management of these
bladder cancer patients.
Acknowledgment
The authors would like to thank the Chang Gung Memorial Hospital (Contract No. CMRPG1006) for financial
support of this research.
References
1 Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Franmeit JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst
1995; 87: 175-82.
2 Pu YS. Prostate cancer in Taiwan: Epidemiology and risk
factors. Int J Androl 2000; 23 (Suppl. 2):34-6.
3 ScottR Jr, Matchnik DH, Laskowski TZ, Schmalfrost WR. Carcinoma of the prostate in the elderly men:
incidence, growth characteristics and clinical significance. J Urol 1969; 101: 602-7.
4 Gu FL, Xia TL, Kong XT. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology
1994; 44: 688-91.
5 Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85:
60-7
6 Abbas F, Hoshberg D, Givantos F, Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy
for bladder cancer. Eur Urol 1996; 30: 322-6.
7 Montie JE, Wood DR Jr, Pontes E, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed
for bladder cancer. Cancer 1989; 63: 381-5.
8 Moutzouris G, Barbatis C, Plastiras D, Mertziotis N, Katsifotis C, Presvelos V,
et al. Incidence and histological findings of
unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol
1999; 33: 27-30.
9 Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB. Incidence and location of prostate and urothelial carcinoma
in prostates from cystoprostatectomies: Implications for possible apical spring surgery. J Urol 2004; 171: 646-51.
|